{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T18:05:49Z","timestamp":1792605949970,"version":"4.5.0"},"reference-count":88,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T00:00:00Z","timestamp":1651622400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Aristolochic acid nephropathy (AAN) is a progressive tubulointerstitial nephritis caused by the intake of aristolochic acids (AA) contained in Chinese herbal remedies or contaminated food. AAN is characterized by tubular atrophy and interstitial fibrosis, characterizing advanced kidney disease. It is established that sustained or recurrent acute kidney injury (AKI) episodes contribute to the progression of CKD. Therefore, the study of underlying mechanisms of AA-induced nephrotoxicity could be useful in understanding the complex AKI-to-CKD transition. We developed a translational approach of AKI-to-CKD transition by reproducing human AAN in rodent models. Indeed, in such models, an early phase of acute tubular necrosis was rapidly followed by a massive interstitial recruitment of activated monocytes\/macrophages followed by cytotoxic T lymphocytes, resulting in a transient AKI episode. A later chronic phase was then observed with progressive tubular atrophy related to dedifferentiation and necrosis of tubular epithelial cells. The accumulation of vimentin and \u03b1SMA-positive cells expressing TGF\u03b2 in interstitial areas suggested an increase in resident fibroblasts and their activation into myofibroblasts resulting in collagen deposition and CKD. In addition, we identified 4 major actors in the AKI-to-CKD transition: (1) the tubular epithelial cells, (2) the endothelial cells of the interstitial capillary network, (3) the inflammatory infiltrate, and (4) the myofibroblasts. This review provides the most comprehensive and informative data we were able to collect and examines the pending questions.<\/jats:p>","DOI":"10.3389\/fmed.2022.822870","type":"journal-article","created":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T11:19:05Z","timestamp":1651663145000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":42,"title":["Experimental Aristolochic Acid Nephropathy: A Relevant Model to Study AKI-to-CKD Transition"],"prefix":"10.3389","volume":"9","author":[{"given":"Thomas","family":"Baudoux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00e8s","family":"Jadot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Emilie","family":"Decl\u00e8ves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-H\u00e9l\u00e8ne","family":"Antoine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marie","family":"Colet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Botton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"De Prez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Pozdzik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Husson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Caron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00eblle L.","family":"Nortier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/sj.ki.5002086","article-title":"Long-term outcome of acute tubular necrosis: a contribution to its natural history","volume":"71","author":"Liano","year":"2007","journal-title":"Kidney Int."},{"key":"B2","first-page":"45","article-title":"Time of death, recovery of renal function, development of chronic renal failure and need for chronic hemodialysis in patients with acute tubular necrosis","volume":"27","author":"Kjellstrand","year":"1981","journal-title":"Trans Am Soc Artif Intern Organs."},{"key":"B3","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1681\/ASN.2007080837","article-title":"Acute kidney injury increases risk of ESRD among elderly","volume":"20","author":"Ishani","year":"2009","journal-title":"J Am Soc Nephrol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1038\/ki.2009.289","article-title":"Dialysis-requiring acute renal failure increases the risk of progressive chronic kidney disease","volume":"76","author":"Lo","year":"2009","journal-title":"Kidney Int."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1038\/ki.2009.332","article-title":"Outcomes following diagnosis of acute renal failure in U.S. veterans: focus on acute tubular necrosis","volume":"76","author":"Amdur","year":"2009","journal-title":"Kidney Int."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1001\/jama.2009.1322","article-title":"Chronic dialysis and death among survivors of acute kidney injury requiring dialysis","volume":"302","author":"Wald","year":"2009","journal-title":"JAMA."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1001\/jama.290.10.1360","article-title":"Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome: a systematic review, meta-analysis, and meta-regression","volume":"290","author":"Garg","year":"2003","journal-title":"JAMA."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1038\/ki.2011.42","article-title":"The severity of acute kidney injury predicts progression to chronic kidney disease","volume":"79","author":"Chawla","year":"2011","journal-title":"Kidney Int."},{"key":"B9","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1056\/NEJMra1214243","article-title":"Acute kidney injury and chronic kidney disease as interconnected syndromes","volume":"371","author":"Chawla","year":"2014","journal-title":"N Engl J Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"F1098","DOI":"10.1152\/ajprenal.00199.2018","article-title":"Rodent models of AKI-CKD transition","volume":"315","author":"Fu","year":"2018","journal-title":"Am J Physiol Renal Physiol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/0140-6736(93)92984-2","article-title":"Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs","volume":"341","author":"Vanherweghem","year":"1993","journal-title":"Lancet."},{"key":"B12","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/S0272-6386(12)80178-8","article-title":"Pathologic aspects of a newly described nephropathy related to the prolonged use of Chinese herbs","volume":"24","author":"Depierreux","year":"1994","journal-title":"Am J Kidney Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1093\/carcin\/9.2.297","article-title":"DNA adduct formation of aristolochic acid I and II in vitro and in vivo","volume":"9","author":"Schmeiser","year":"1988","journal-title":"Carcinogenesis"},{"key":"B14","first-page":"5464","article-title":"Aristolochic acid activates ras genes in rat tumors at deoxyadenosine residues","volume":"50","author":"Schmeiser","year":"1990","journal-title":"Cancer Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/0304-3835(91)90178-K","article-title":"Activating mutations at codon 61 of the c-Ha-ras gene in thin-tissue sections of tumors induced by aristolochic acid in rats and mice","volume":"59","author":"Schmeiser","year":"1991","journal-title":"Cancer Lett."},{"key":"B16","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1093\/carcin\/22.1.133","article-title":"Sequence-specific detection of aristolochic acid-DNA adducts in the human p53 gene by terminal transferase-dependent PCR","volume":"22","author":"Arlt","year":"2001","journal-title":"Carcinogenesis."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1053\/j.ajkd.2003.11.024","article-title":"DNA adducts and p53 mutations in a patient with aristolochic acid-associated nephropathy","volume":"43","author":"Lord","year":"2004","journal-title":"Am J Kidney Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1056\/NEJM200006083422301","article-title":"Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi)","volume":"342","author":"Nortier","year":"2000","journal-title":"N Engl J Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1007\/s00204-016-1819-3","article-title":"Balkan endemic nephropathy: an update on its aetiology","volume":"90","author":"Stiborova","year":"2016","journal-title":"Arch Toxicol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.semnephrol.2019.02.007","article-title":"Balkan endemic nephropathy and the causative role of aristolochic acid","volume":"39","author":"Jelakovi\u0107","year":"2019","journal-title":"Semin Nephrol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1749-8546-3-13","article-title":"Prescription profile of potentially aristolochic acid containing Chinese herbal products: an analysis of National Health Insurance data in Taiwan between 1997 and 2003","volume":"3","author":"Hsieh","year":"2008","journal-title":"Chin Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/em.21756","article-title":"Aristolochic acid nephropathy: harbinger of a global iatrogenic disease","volume":"54","author":"Grollman","year":"2013","journal-title":"Environ Mol Mutagen."},{"key":"B23","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/ki.2008.129","article-title":"Aristolochic acid nephropathy: a worldwide problem","volume":"74","author":"Debelle","year":"2008","journal-title":"Kidney Int."},{"key":"B24","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3390\/ijms18020297","article-title":"An integrated view of aristolochic acid nephropathy: update of the literature","volume":"18","author":"Jadot","year":"2017","journal-title":"Int J Mol Sci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1046\/j.1523-1755.2001.00731.x","article-title":"Chronic aristolochic acid toxicity in rabbits: a model of Chinese herbs nephropathy?","volume":"59","author":"Cosyns","year":"2001","journal-title":"Kidney Int."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1093\/ndt\/gfi042","article-title":"Early proximal tubule injury in experimental aristolochic acid nephropathy: functional and histological studies","volume":"20","author":"Lebeau","year":"2005","journal-title":"Nephrol Dial Transplant."},{"key":"B27","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/sj.ki.5002714","article-title":"Aristolochic acid induces proximal tubule apoptosis and epithelial to mesenchymal transformation","volume":"73","author":"Pozdzik","year":"2008","journal-title":"Kidney Int."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1038\/ki.2012.264","article-title":"Probenecid prevents acute tubular necrosis in a mouse model of aristolochic acid nephropathy","volume":"82","author":"Baudoux","year":"2012","journal-title":"Kidney Int."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e0183604","DOI":"10.1371\/journal.pone.0183604","article-title":"Restored nitric oxide bioavailability reduces the severity of acute-to-chronic transition in a mouse model of aristolochic acid nephropathy","volume":"12","author":"Jadot","year":"2017","journal-title":"PLoS ONE."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2480","DOI":"10.1093\/ndt\/gfn140","article-title":"Patterns of interstitial inflammation during the evolution of renal injury in experimental aristolochic acid nephropathy","volume":"23","author":"Pozdzik","year":"2008","journal-title":"Nephrol Dial Transplant."},{"key":"B31","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1038\/kisup.2014.2","article-title":"Overview of the cellular and molecular basis of kidney fibrosis","volume":"4","author":"Eddy","year":"2014","journal-title":"Kidney Int."},{"key":"B32","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.tox.2009.07.014","article-title":"Molecular evidence for an involvement of organic anion transporters (OATs) in aristolochic acid nephropathy","volume":"264","author":"Bakhiya","year":"2009","journal-title":"Toxicology."},{"key":"B33","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1254\/jphs.09339SC","article-title":"Interactions of human organic anion transporters with aristolochic acids","volume":"113","author":"Babu","year":"2010","journal-title":"J Pharmacol Sci."},{"key":"B34","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1021\/mp100418u","article-title":"Critical role of organic anion transporters 1 and 3 in kidney accumulation and toxicity of aristolochic acid I","volume":"8","author":"Xue","year":"2011","journal-title":"Mol Pharm."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1124\/dmd.107.014688","article-title":"Selective toxicity of aristolochic acids I and II","volume":"35","author":"Shibutani","year":"2007","journal-title":"Drug Metab Dispos."},{"key":"B36","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1093\/ndt\/18.2.426","article-title":"Invasive urothelial carcinoma after exposure to Chinese herbal medicine containing aristolochic acid may occur without severe renal failure","volume":"18","author":"Nortier","year":"2003","journal-title":"Nephrol Dial Transplant."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1007\/s10495-006-0289-0","article-title":"Effect of aristolochic acid on intracellular calcium concentration and its links with apoptosis in renal tubular cells","volume":"11","author":"Hsin","year":"2006","journal-title":"Apoptosis."},{"key":"B38","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.tiv.2012.03.005","article-title":"Endoplasmic reticulum stress mediates aristolochic acid I-induced apoptosis in human renal proximal tubular epithelial cells","volume":"26","author":"Zhu","year":"2012","journal-title":"Toxicol In Vitro."},{"key":"B39","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.taap.2007.03.029","article-title":"Role of mitochondrial permeability transition in human renal tubular epithelial cell death induced by aristolochic acid","volume":"222","author":"Qi","year":"2007","journal-title":"Toxicol Appl Pharmacol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.tiv.2011.01.016","article-title":"Aristolochic acid I induced oxidative DNA damage associated with glutathione depletion and ERK1\/2 activation in human cells","volume":"25","author":"Yu","year":"2011","journal-title":"Toxicol In Vitro."},{"key":"B41","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.bbrc.2012.06.049","article-title":"Aristolochic acid-induced accumulation of methylglyoxal and Nepsilon-(carboxymethyl)lysine: an important and novel pathway in the pathogenic mechanism for aristolochic acid nephropathy","volume":"423","author":"Li","year":"2012","journal-title":"Biochem Biophys Res Commun."},{"key":"B42","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s11255-011-0082-z","article-title":"Glutathione S-transferases T1 null genotype is associated with susceptibility to aristolochic acid nephropathy","volume":"44","author":"Chen","year":"2012","journal-title":"Int Urol Nephrol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3892\/or_00000839","article-title":"Aristolochic acid suppresses DNA repair and triggers oxidative DNA damage in human kidney proximal tubular cells","volume":"24","author":"Chen","year":"2010","journal-title":"Oncol Rep."},{"key":"B44","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00204-014-1249-z","article-title":"Aristolochic acid-induced apoptosis and G2 cell cycle arrest depends on ROS generation and MAP kinases activation","volume":"89","author":"Romanov","year":"2015","journal-title":"Arch Toxicol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1038\/nri3523","article-title":"The immune system and kidney disease: basic concepts and clinical implications","volume":"13","author":"Kurts","year":"2013","journal-title":"Nat Rev Immunol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/nm.2144","article-title":"Epithelial cell cycle arrest in G2\/M mediates kidney fibrosis after injury","volume":"16","author":"Yang","year":"2010","journal-title":"Nat Med."},{"key":"B47","doi-asserted-by":"publisher","first-page":"S39","DOI":"10.1038\/kisup.2014.8","article-title":"Primary proximal tubule injury leads to epithelial cell cycle arrest, fibrosis, vascular rarefaction, and glomerulosclerosis","volume":"4","author":"Bonventre","year":"2014","journal-title":"Kidney Int."},{"key":"B48","doi-asserted-by":"publisher","first-page":"F284","DOI":"10.1152\/ajprenal.00317.2011","article-title":"The p53 inhibitor pifithrin-alpha can stimulate fibrosis in a rat model of ischemic acute kidney injury","volume":"302","author":"Dagher","year":"2012","journal-title":"Am J Physiol Renal Physiol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"2707","DOI":"10.1681\/ASN.2013121270","article-title":"Targeted deletion of p53 in the proximal tubule prevents ischemic renal injury","volume":"25","author":"Ying","year":"2014","journal-title":"J Am Soc Nephrol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"3345","DOI":"10.1007\/s00204-019-02578-4","article-title":"The impact of p53 on aristolochic acid I-induced nephrotoxicity and DNA damage in vivo and in vitro","volume":"93","author":"Sborchia","year":"2019","journal-title":"Arch Toxicol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.fct.2017.07.015","article-title":"Interest of metabonomic approach in environmental nephrotoxicants: application to aristolochic acid exposure","volume":"108","author":"Duquesne","year":"2017","journal-title":"Food Chem Toxicol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/nrneph.2014.246","article-title":"Diverse origins of the myofibroblast-implications for kidney fibrosis","volume":"11","author":"Falke","year":"2015","journal-title":"Nat Rev Nephrol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1002\/cphy.c110041","article-title":"Pathophysiology of acute kidney injury","volume":"2","author":"Basile","year":"2012","journal-title":"Compr Physiol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1186\/1755-1536-5-S1-S15","article-title":"Progression of renal fibrosis: the underestimated role of endothelial alterations","volume":"5","author":"Guerrot","year":"2012","journal-title":"Fibrogenesis Tissue Repair."},{"key":"B55","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1146\/annurev-med-050214-013407","article-title":"Acute kidney injury","volume":"67","author":"Zuk","year":"2016","journal-title":"Annu Rev Med."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1016\/j.cca.2010.06.019","article-title":"Mechanism of endothelial dysfunction in chronic kidney disease","volume":"411","author":"Malyszko","year":"2010","journal-title":"Clin Chim Acta."},{"key":"B57","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1093\/ckj\/sfx133","article-title":"Capillary rarefaction from the kidney point of view","volume":"11","author":"Afsar","year":"2018","journal-title":"Clin Kidney J."},{"key":"B58","doi-asserted-by":"publisher","first-page":"F1","DOI":"10.1152\/ajprenal.00424.2007","article-title":"Nitric oxide deficiency in chronic kidney disease","volume":"294","author":"Baylis","year":"2008","journal-title":"Am J Physiol Renal Physiol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"F1078","DOI":"10.1152\/ajprenal.00017.2010","article-title":"Acute kidney injury: a springboard for progression in chronic kidney disease","volume":"298","author":"Venkatachalam","year":"2010","journal-title":"Am J Physiol Renal Physiol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/nrneph.2011.219","article-title":"Restoring the renal microvasculature to treat chronic kidney disease","volume":"8","author":"Long","year":"2012","journal-title":"Nat Rev Nephrol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1172\/JCI72269","article-title":"Therapeutic translation in acute kidney injury: the epithelial\/endothelial axis","volume":"124","author":"Molitoris","year":"2014","journal-title":"J Clin Invest."},{"key":"B62","doi-asserted-by":"publisher","first-page":"F721","DOI":"10.1152\/ajprenal.00546.2010","article-title":"Impaired endothelial proliferation and mesenchymal transition contribute to vascular rarefaction following acute kidney injury","volume":"300","author":"Basile","year":"2011","journal-title":"Am J Physiol Renal Physiol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1159\/000094778","article-title":"Role of peritubular capillary loss and hypoxia in progressive tubulointerstitial fibrosis in a rat model of aristolochic acid nephropathy","volume":"26","author":"Sun","year":"2006","journal-title":"Am J Nephrol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1093\/ndt\/gfl556","article-title":"Possible mechanisms explaining the tendency towards interstitial fibrosis in aristolochic acid-induced acute tubular necrosis","volume":"22","author":"Yang","year":"2007","journal-title":"Nephrol Dial Transplant."},{"key":"B65","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.trsl.2008.05.002","article-title":"Ischemic injury underlies the pathogenesis of aristolochic acid-induced acute kidney injury","volume":"152","author":"Wen","year":"2008","journal-title":"Transl Res."},{"key":"B66","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1113\/EP085333","article-title":"Protective effect of nitric oxide in aristolochic acid-induced toxic acute kidney injury: an old friend with new assets","volume":"101","author":"Decleves","year":"2016","journal-title":"Exp Physiol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1038\/aps.2011.74","article-title":"Aristolochic acid induces apoptosis of human umbilical vein endothelial cells in vitro by suppressing PI3K\/Akt signaling pathway","volume":"32","author":"Shi","year":"2011","journal-title":"Acta Pharmacol Sin."},{"key":"B68","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.toxlet.2018.10.022","article-title":"Aristolochic acid inhibits Slit2-induced migration and tube formation via inactivation of Robo1\/Robo2-NCK1\/NCK2 signaling pathway in human umbilical vein endothelial cells","volume":"300","author":"Guan","year":"2019","journal-title":"Toxicol Lett."},{"key":"B69","doi-asserted-by":"publisher","first-page":"104811","DOI":"10.1016\/j.tiv.2020.104811","article-title":"Characterization of cytotoxic effects of aristolochic acids on the vascular endothelium","volume":"65","author":"Youl","year":"2020","journal-title":"Toxicol In Vitro."},{"key":"B70","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0272-6386(96)90542-9","article-title":"Effects of steroids on the progression of renal failure in chronic interstitial renal fibrosis: a pilot study in Chinese herbs nephropathy","volume":"27","author":"Vanherweghem","year":"1996","journal-title":"Am J Kidney Dis."},{"key":"B71","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1093\/ndt\/17.11.2033-a","article-title":"Steroid therapy in chronic interstitial renal fibrosis: the case of Chinese-herb nephropathy","volume":"17","author":"Martinez","year":"2002","journal-title":"Nephrol Dial Transplant."},{"key":"B72","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1111\/j.1365-2559.2010.03509.x","article-title":"Aristolochic acid nephropathy revisited: a place for innate and adaptive immunity?","volume":"56","author":"Pozdzik","year":"2010","journal-title":"Histopathology."},{"key":"B73","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1191\/0960327105ht502oa","article-title":"Mast cell infiltration associated with tubulointerstitial fibrosis in chronic Aristolochic Acid Nephropathy","volume":"24","author":"Wu","year":"2005","journal-title":"Hum Exp Toxicol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nrneph.2014.180","article-title":"Immune cells in experimental acute kidney injury","volume":"11","author":"Jang","year":"2015","journal-title":"Nat Rev Nephrol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"156","DOI":"10.4172\/2157-7099.1000186","article-title":"CD44 positive cells and hyaluronan are a hallmark of a rat model of aristolochic acid nephropathy","volume":"4","author":"Decleves A","year":"2013","journal-title":"J Cytol Histol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"3771","DOI":"10.1093\/ndt\/gfs098","article-title":"Synthesis and fragmentation of hyaluronan in renal ischaemia","volume":"27","author":"Decleves","year":"2012","journal-title":"Nephrol Dial Transplant."},{"key":"B77","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1681\/ASN.2008010123","article-title":"Tracking the toll of kidney disease","volume":"19","author":"Shirali","year":"2008","journal-title":"J Am Soc Nephrol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3892\/ijmm.18.1.83","article-title":"Dynamics of hyaluronan, CD44, and inflammatory cells in the rat kidney after ischemia\/reperfusion injury","volume":"18","author":"Decl\u00e8ves","year":"2006","journal-title":"Int J Mol Med."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1681\/ASN.2014010117","article-title":"Beyond tissue injury-damage-associated molecular patterns, toll-like receptors, and inflammasomes also drive regeneration and fibrosis","volume":"25","author":"Anders","year":"2014","journal-title":"J Am Soc Nephrol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"5334","DOI":"10.1038\/s41598-018-23565-2","article-title":"CD4(+) and CD8(+) T cells exert regulatory properties during experimental acute aristolochic acid nephropathy","volume":"8","author":"Baudoux","year":"2018","journal-title":"Sci Rep."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1681\/ASN.2015010006","article-title":"Failed tubule recovery, AKI-CKD transition, and kidney disease progression","volume":"26","author":"Venkatachalam","year":"2015","journal-title":"J Am Soc Nephrol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1172\/JCI44595","article-title":"Epithelial-mesenchymal transition (EMT) in kidney fibrosis: fact or fantasy?","volume":"121","author":"Kriz","year":"2011","journal-title":"J Clin Invest."},{"key":"B83","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/nrneph.2015.3","article-title":"Mechanisms of maladaptive repair after AKI leading to accelerated kidney ageing and CKD","volume":"11","author":"Ferenbach","year":"2015","journal-title":"Nat Rev Nephrol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"e0157288","DOI":"10.1371\/journal.pone.0157288","article-title":"Blocking TGF-\u03b2 signaling pathway preserves mitochondrial proteostasis and reduces early activation of PDGFR\u03b2+ pericytes in aristolochic acid induced acute kidney injury in wistar male rats","volume":"11","author":"Pozdzik","year":"2016","journal-title":"PLoS ONE."},{"key":"B85","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1159\/000363681","article-title":"How can we define recovery after acute kidney injury? Considerations from epidemiology and clinical trial design","volume":"127","author":"Kellum","year":"2014","journal-title":"Nephron Clin Pract."},{"key":"B86","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/ALN.0000000000001400","article-title":"Rapid occurrence of chronic kidney disease in patients experiencing reversible acute kidney injury after cardiac surgery","volume":"126","author":"Legouis","year":"2017","journal-title":"Anesthesiology."},{"key":"B87","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1038\/ki.2015.230","article-title":"A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010","volume":"88","author":"Mills","year":"2015","journal-title":"Kidney Int."},{"key":"B88","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/S0140-6736(13)60687-X","article-title":"Chronic kidney disease: global dimension and perspectives","volume":"382","author":"Jha","year":"2013","journal-title":"Lancet."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.822870\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T11:19:11Z","timestamp":1651663151000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.822870\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,4]]},"references-count":88,"alternative-id":["10.3389\/fmed.2022.822870"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.822870","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,4]]},"article-number":"822870"}}